Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Discover how CA8 may influence liver glucose production and pancreatic insulin secretion, revealing a possible new link in type 2 diabetes.
Read More »One Molecular Switch, Two Organs: A New Clue to Type 2 Diabetes
High-Fiber Diet vs. Metformin: A Small Trial Delivers a Surprising Result
A small 84-day trial found greater A1C and BMI improvements with a high-fiber diet than metformin. Explore the results, limitations, and clinical implications.
Read More »After DKA or Repeated Low Blood Sugar, Could Attention Problems Linger?
Explore how hypoglycemia and DKA may be linked to attention difficulties in children with type 1 diabetes and what new research reveals.
Read More »Feeding at Night, Dosing by Day: Why Parenteral Nutrition Makes Insulin Management So Difficult
Discover why parenteral nutrition complicates insulin dosing and how CGM-guided adjustments improved glucose control in a small clinical study.
Read More »High Altitude, Low Oxygen, Same CGM? Researchers Put Sensor Accuracy to the Test
New research examines CGM accuracy in hypoxia, including Dexcom G6 and FreeStyle Libre performance during reduced oxygen exposure.
Read More »Type 1 Diabetes Care Just Changed: The 2026 ADA/EASD Update Clinicians Need to Know
The type 1 diabetes consensus 2026 expands guidance on AID, cardiovascular risk, obesity, complications, psychosocial care, and new therapies.
Read More »Pump or Smart Pen? A Head-to-Head Trial Finds There May Be More Than One Right Answer
A head-to-head trial compared a smart insulin pen vs AID in adults with type 1 diabetes. See who benefited most and why patient preference still matters.
Read More »Gestational Diabetes Without Going Low-Carb? A Trial Tests a Different Nutrition Strategy
A randomized trial compares complex carbohydrates with a lower-carb diet in gestational diabetes and explores what the findings mean for nutrition counseling.
Read More »Three Weeks of Treatment, Months of Better Glucose? A New Diabetes Drug Is Testing an Unusual Idea
Early Phase 1b data suggest balomenib may improve glucose control after treatment ends. Learn what the results could mean for type 2 diabetes.
Read More »Sex and Blood Sugar: Does Intimacy Put People With Type 1 Diabetes at Risk for Hypoglycemia?
A small CGM study explores whether sexual activity increases hypoglycemia risk in adults with type 1 diabetes and what the findings mean for care.
Read More »